Radiation/nuclear medical countermeasure product development support services

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201000046C
Awardee
Awarding agency
Obligated
$64,358,507

Award facts

Opportunity
Contract value 79% obligated
  • $64,358,506.96 Current, with exercised options
  • $81,904,328.96 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 17 -$0
Other Administrative Action 16 $0
Supplemental Agreement for work within scope 15 $301,296
Funding Only Action 14 $1,033,581
Funding Only Action 13 $218,746
Funding Only Action 12 $177,737
Exercise an Option 11 $9,989,416
Exercise an Option 10 $999,802
Exercise an Option 9 $9,998,014
Exercise an Option 8 $9,427,820
Other Administrative Action 7 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Exercise an Option 4 $997,084
Funding Only Action 3 $6,992,418
Other Administrative Action 2 $0
Exercise an Option 1 $9,970,834
Original award $14,251,759
Show all 18

About this award

This is a $81,904,328.96 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) for radiation/nuclear medical countermeasure product development support services.

The contract supports the development of medical countermeasures against radiation and nuclear threats, which aligns with NIAID's mission to conduct and support research to understand, treat, and prevent infectious, immunologic, and allergic diseases. UMB, a major public research university, will provide a range of goods and services including biomedical and clinical research, healthcare services, professional education, and community outreach to advance these critical medical countermeasure capabilities. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract HHSN272201000046C?

HHSN272201000046C was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 27, 2010.

How much is contract HHSN272201000046C worth?

The government has obligated $64,358,507 on HHSN272201000046C. Its potential value, with all options, is $81,904,329.

Was contract HHSN272201000046C competed?

The extent of competition for HHSN272201000046C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award